Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case.
This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. SKIN CANCER BIOLOGY AND ITS BIOMARKERS:RECENT TRENDS AND PROSPECTIVEHimani Sharma
2. ROLE OF BIOMARKERS IN ASSESSING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER TREATMENT
Shyam Aggarwal
3. GENOTYPE INFLUENCED PHARMACOKINETICS OF ANTI-CANCER MEDICINE: A CONNECTING LINK
Shamsher Singh
4. GENETIC PREDISPOSITION AND PATHOPHYSIOLOGY OF ORAL SQUAMOUS CELL CARCINOMA
Gowtham Kumar Subbaraj
5. ORAL SQUAMOUS CELL CARCINOMA
Anubha Gulati
6. SHARED AND DISTINCT ASPECTS OF HEMATOPOIETIC MALIGNANCIES SUCH AS LEUKEMIA AND LYMPHOMA
Ramakrishnan Veerabathiran
7. MOLECULAR DIAGNOSIS, DRIVERS AND TREATMENT LYMPHOCYTIC LEUKEMIA
Saurabh Yadav
8. MYELODYSPLASTIC SYNDROME A CHALLENGING ENTITY
Anshu Palta
9. MULTIPLE MYELOMA
Vijay Goni
10. MOLECULAR BIOMARKERS IN PROSTATE CANCER
KATSUNORI UCHIDA and Remi Semba
11. GENETICS OF NEURONAL AND GLIONEURONAL CANCERS
Anshika Srivastava
12. RECENT ADVANCEMENT IN MOLECULAR MARKER OF PANCREATIC CANCER
Kanagaraj Palaniyandi
13. MOLECULAR BIOMARKERS IN GASTRIC CANCER
Yoshifumi S. Hirokawa and Kazuki Kanayama
14. MOLECULAR BIOMARKERS IN PANCREATIC DUCTAL ADENOCARCINOMA
Yoshifumi S. Hirokawa, Reiko Yamada and Junya Tsuboi
15. BIOMARKERS IN ENDOMTRIAL AND CERVICAL CANCER
Aashima Arora
16. BIOMARKERS IN ENDOCRINE DISEASES
Sunil Chumber and Dhritiman Maitra
17. CANCER IMMUNOTHERAPY ASSOCIATED ENDOCRINE COMPLICATIONS
Kousik Pramanick
18. THERAPEUTIC POTENTIAL OF MELATONIN IN GLIOBLASTOMA: CURRENT KNOWLEDGE AND FUTURE PROSPECTS
Nithar Ranjan Madhu Sr.
19. ANTICANCER ACTIVITIES OF MACROMOLECULES OFMARINE ORIGIN: CLINICAL EVIDENCE
Maushmi Shailesh Kumar
20. NANOPARTICLES AS A MEANS OF DRUG DELIVERY IN CANCER THERAPY
Olorunfemi Raphael Molehin
21. THERAPEUTIC POTENTIAL OF MICROALGAE AND THEIR PROSPECTS IN TARGETED DELIVERY IN CANCER MANAGEMENT
Maushami Kumar and Maushmi Shailesh Kumar
22. PROSPECTS OF MANGROVE DERIVED PHYTOCHEMICALS IN CANCER RESEARCH
Punarbasu Choawdhury
23. PHYTOCHEMICALS AND MIRNA BASED THERAPEUTIC OPPORTUNITIES FOR CANCER STEM CELL MEDIATED TUMOR ANGIOGENESIS
Anandan Balakrishnan
24. EMERGENCE OF METAL-BASED ANTICANCER THERAPEUTICS: A PROMISING PERSPECTIVE
Suman Adhikari
25. NEW INFRARED (NIR) RESPONSE NANOMATERIAL LIPOSOME NANOHYBRID FOR CANCER PHOTO THERMAL
Animesh Pan
26. IMPACT OF PESTICIDES ON IMMUNE-ENDOCRINE DISORDERS AND ITS RELATIONSHIP TO CANCER DEVELOPMENT
Carolina Panis
Authors
Ranbir Chander Sobti Senior Scientist and Professor Emeritus, Department of Biotechnology, Panjab University, Chandigarh, India. Professor Sobti is an Education Consultant Governor of Bihar and Senior Scientist at the Indian National Science Academy, in addition to Former Vice Chancellor at Babasaheb Bhimrao Ambedkar University, Lucknow, and Panjab University, Chandigarh, India.Beginning his career as a Cytogeneticist, Professor Sobti moved on to explore the role of gene polymorphisms and their expression in the genesis of various cancers, COPD, AIDS and metabolic syndrome. He has identified disease susceptible / protective novel genotypes and determined the crucial role of SACS-1 and STAT genes in the genesis of cervical and prostate cancers. He has contributed to 270 research publications, 35 books and 23 sponsored research projects. He has received prestigious awards and medals, including the honor of "Padma Shri� from the Government of India for his contribution to higher education. Additionally he was honored with 'Bharat Gaurav', Lifetime Achievement Award at the House of Commons, British Parliament, London, UK. Masatoshi Watanabe Professor and Chairman, Department of Tumor Pathology, Hamamatsu University School of Medicine, Japan.
Dr.Watanabe graduated from Yokohama National University, Faculty of Engineering (1983), and Mie University, Faculty of Medicine (1989). He obtained a doctor in Medicine from Mie University (1993). He was a professor at Graduate School of Engineering, Yokohama national University (2003-2017), and also a guest professor at School of Medicine, Yokohama City University (2011-1017). He was a visiting fellow in NIH/NIEHS (1997-1999, Dr. J. Carl Barrett). He is now a professor, at School of Medicine, Mir University (2017-). He has published more than 130 scientific publications. He is a member and councilor in Japanese Society of Pathology, and in Japanese Cancer Association.
Aastha Sobti Doctoral student, Department of Immunotechnology, Lund University, Lund, Sweden. Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025).
